Assigned group	Age (years)	Gender	Weight in pounds/BMI	Baseline A1c	Reason for withdrawal	Final outcome after withdrawal
Control	77	M	230/35	9.4%	He wanted to switch MDI to the intervention group and refused to remain in control group.	Taking the study medications from PCP.
Control	59	F	208/31.6	8.3%	PCP discontinued basal prandial insulin.	Taking U‐500 insulin.
Intervention	28	F	186.6/32.2	9.1%	Lost to follow‐up/did not return to 3rd visit	She continues to take the same study medication through PCP.
Intervention	27	F	223.4/43.1	11.4%	adverse event (nausea/vomiting/headache)	Withdrew from study after 3 weeks. Complete resolution of symptoms after stopping study medications.

PCP, Primary Care Provider.